Accidentally taking your antiretroviral (ARV) medication twice in one day is unlikely to cause serious harm. A large review of double-dose medication ingestions reported to a major poison control system found that antimicrobials, which include antiretrovirals, were generally well tolerated at double the prescribed amount. That said, depending on which specific drugs make up your regimen, you may notice amplified side effects for a day or so, and there are a few situations where extra caution is warranted.
Why a Single Double Dose Is Usually Not Dangerous
ARVs are designed with a reasonable safety margin between the dose that works and the dose that starts causing problems. When you take a double dose, the peak drug concentration in your blood goes up, but your body keeps metabolizing the medication at roughly the same rate. That means the extra drug clears out over the following hours, and the temporary spike usually falls within a range your body can handle without lasting consequences.
A ten-year review of single-medication double-dose ingestions reported to the largest poison control network in the United States looked at hundreds of cases across many drug classes. The medications most likely to cause moderate or major effects were blood pressure drugs and drugs that affect heart rhythm or mood. Antimicrobials and analgesics, on the other hand, were well tolerated, and there were no deaths in the entire dataset.1Clinical Toxicology. A 10-year review of single medication double-dose ingestions in the nation’s largest poison control system ARVs fall into the antimicrobial category, and their therapeutic index (the gap between an effective dose and a harmful one) is generally wide enough that doubling up once does not push you into dangerous territory.
This does not mean a double dose has zero effect on your body. What it means is that, for most people on most ARV regimens, the consequences are temporary and mild.
Side Effects You Might Notice
The specific symptoms you experience after an accidental double dose depend heavily on which drugs are in your regimen. ARVs are not a single medication but a combination, and each drug class has its own side-effect profile. Here are the most common patterns.
Stomach and Digestive Issues
Nausea, diarrhea, and general stomach discomfort are among the most frequently reported side effects of many ARV regimens at standard doses, and a double dose can make them worse for a day. Protease inhibitors, especially those boosted with ritonavir or cobicistat, are particularly associated with gastrointestinal symptoms. In a large pooled analysis of patients on darunavir/cobicistat/emtricitabine/tenofovir alafenamide, all gastrointestinal adverse events related to the drug were mild (grade 1 or 2), and diarrhea and nausea each occurred in fewer than one in twenty patients during the first week at standard doses.2Journal of the International Association of Providers of AIDS Care. Low Incidence and Brief Duration of Gastrointestinal Adverse Events with Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Over 96 Weeks At a double dose, you might see more pronounced nausea or loose stools, but these should settle within a day as drug levels return to normal.
Headache and Neurological Symptoms
Some ARVs can cause headache, dizziness, or a feeling of being “off” when blood levels peak. A pharmacokinetic study of the protease inhibitor amprenavir found that headache and oral numbness were the only side effects significantly linked to peak drug concentration in the blood.3Antimicrobial Agents and Chemotherapy. Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing If your regimen includes a protease inhibitor, a higher-than-usual peak from a double dose could temporarily intensify these kinds of symptoms.
Efavirenz and Central Nervous System Effects
If your regimen includes efavirenz, the situation deserves special attention. Efavirenz is well known for causing neuropsychiatric side effects even at standard doses, including vivid dreams, difficulty concentrating, dizziness, and mood changes. These effects are dose-related. An analysis of data from nearly 200 patients on efavirenz-based therapy identified sleep disturbances, hallucinations, and cognitive impairment as key neuropsychiatric symptoms tied to efavirenz exposure.4PubMed. Maximizing Knowledge Extraction From Patient-Reported Outcome Data Using Exposure-Outcome Item Response Modeling Approach: Understanding Efavirenz-Induced Central Nervous System Toxicity At standard doses, these symptoms are common but usually manageable. A double dose could make them considerably more intense, particularly vivid or disturbing dreams, dizziness, or difficulty with focus. In rare cases, efavirenz has even been associated with severe depression and suicidal thoughts at therapeutic doses.5PubMed. Central nervous system adverse effects with efavirenz: case report and review
Efavirenz is used far less frequently in modern first-line regimens than it once was, partly because of these neuropsychiatric effects. But if your regimen still includes it, a double dose is the scenario where you would most want to pay attention to how you are feeling and reach out to a healthcare provider if the psychological effects feel alarming.
What to Do After a Double Dose
The standard medical guidance is straightforward: take your next dose at the normal scheduled time. Do not skip a dose to “make up” for the extra one. Your body metabolizes the drug continuously, and most ARVs are cleared within roughly 12 to 24 hours. Even with a double dose, drug levels will drop back toward normal by the time your next dose is due, so skipping would risk letting your levels fall too low, which is exactly the situation that can allow the virus to develop resistance.
If you experience uncomfortable side effects like nausea or dizziness, they should ease as the extra drug is cleared. Staying hydrated and eating bland food can help with nausea. If symptoms are severe or do not resolve within a day, contact your healthcare provider, but know that a call to say “I doubled up once” is not an emergency in most cases.
Kidney Concerns with Tenofovir
One area where the general reassurance gets a bit more cautious involves tenofovir disoproxil fumarate (TDF), a backbone drug in many ARV regimens worldwide. TDF is well known for its potential to affect kidney function over time, and a sudden spike in blood levels could theoretically stress the kidneys more than usual. A review of case reports involving TDF overdose (in combination with other ARVs) found that most cases resolved without lasting kidney damage, though some showed a transient rise in creatinine, a marker of kidney stress. At least one case of permanent kidney injury has been documented after overdose.6Southern African Journal of HIV Medicine. An overview of tenofovir and renal disease for the HIV-treating clinician
The risk here is dose-dependent and almost certainly greater with intentional overdose than with a one-time accidental doubling. But if you have any pre-existing kidney issues, or if your creatinine levels have been flagged as borderline in past blood work, a double dose of a TDF-containing regimen is worth mentioning to your doctor. They may want to check your kidney function at your next visit.
The newer formulation, tenofovir alafenamide (TAF), achieves the same antiviral effect at a much lower dose and has a milder impact on kidney function and bone mineral density.7PubMed Central. Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis If your regimen uses TAF rather than TDF, the kidney risk from a single double dose is even lower.
When the Extra Dose Matters More
For most healthy adults on a modern ARV regimen, a single double dose is a non-event. But a few situations raise the stakes enough to warrant closer attention:
- Pre-existing kidney disease: As noted above, people with reduced kidney function are more vulnerable to the nephrotoxic effects of certain ARVs, especially TDF. A double dose concentrates that exposure.
- Liver impairment: Many ARVs are metabolized by the liver. If your liver is already compromised by hepatitis co-infection, alcohol use, or another condition, a double dose may clear more slowly, keeping blood levels elevated longer than they would in someone with healthy liver function.
- Efavirenz-based regimens: The dose-dependent neuropsychiatric effects described earlier make efavirenz the ARV class where a double dose is most likely to produce noticeable and uncomfortable symptoms, even if they are not medically dangerous.
- Drug interactions: If you take other medications that compete for the same metabolic pathways, a double dose of ARVs could interact unpredictably. This is especially relevant for people on medications for tuberculosis, seizures, or certain cardiovascular drugs. If you are on a complex medication schedule, let your pharmacist know about the double dose.
None of these scenarios turn a single accidental double dose into a crisis. They simply shift the situation from “nothing to worry about” to “worth a quick call to your provider.”
Children and Accidental Ingestion
The picture changes meaningfully when the person who took the extra dose is a child. Pediatric ARV dosing is carefully weight-adjusted, so even a moderate excess above the intended dose represents a proportionally larger increase. A case report from South Africa described a child who ingested far more than the recommended upper daily limits of abacavir (16 mg per kg, capped at 600 mg per day) and lamivudine (10 mg per kg, capped at 300 mg per day).8PubMed Central. Paediatric antiretroviral overdose: A case report from a resource-poor area Pediatric doses are dispensed in small increments precisely to reduce the risk of toxicity, and the gap between a therapeutic dose and an excessive one is narrower in children than in adults.
If a child accidentally takes a double dose, contacting a healthcare provider or a poison control center is the right move. This is not necessarily because the double dose will cause harm, but because the margin of safety is slimmer, and a medical professional can quickly assess whether observation at home is enough or whether the child needs monitoring. If the child has access to liquid ARV formulations, caregivers should also be aware that these are sometimes sweetened and might be more appealing to young children than tablets, making accidental re-dosing or exploratory ingestion a real possibility.
How It Happens and How to Prevent It
Forgetting whether you already took your dose is the most common reason people end up doubling. It tends to happen when your routine is disrupted: travel, a change in schedule, early mornings when you are half-asleep, or simply a moment of distraction. For people who have been on daily ARVs for years, the act of taking a pill can become so automatic that you genuinely cannot remember doing it ten minutes later.
Practical solutions are low-tech but effective. A weekly pill organizer is the simplest: if today’s compartment is empty, you have already taken your dose. Phone alarms work too, but only if you take the medication right when the alarm goes off rather than dismissing it with the intention to take it “in a minute.” Some people leave the pill bottle in a specific spot and flip it upside-down after taking their dose, then right it again at the end of the day.
The emotional dimension here is worth acknowledging. Daily pill-taking is not just a logistical challenge. In a large international survey of people living with HIV, about a third reported that having to remember their medication every day caused them stress or anxiety, and nearly six in ten said that taking daily pills served as a constant reminder of their HIV status.9PubMed Central. Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study That kind of psychological weight can itself contribute to dosing mistakes, because the anxiety around medication can lead to rumination (“did I take it or not?”) and paradoxically, to either double-dosing or skipping out of avoidance.
Long-Acting Alternatives and the Future of Dosing Errors
One reason dosing errors remain so common is that the dominant model for ARV therapy is still a daily oral pill. That model has been extraordinarily effective at controlling HIV, but it asks a lot of the person taking it: perfect consistency, day after day, for life. The anxiety and cognitive burden that come with that task are real, and the occasional double dose or missed dose is an almost inevitable byproduct.
Long-acting injectable ARVs, which are given as an intramuscular injection every one to two months, eliminate the daily dosing question entirely. You cannot accidentally take a long-acting injection twice in one day because the injection is administered by a healthcare professional in a clinical setting. For people who find daily pills stressful, who travel frequently, or who have had repeated issues with dosing errors, injectables remove the entire category of problem. They are not available everywhere and are not suitable for every patient, but their existence represents a real shift in how the daily burden of ARV therapy can be managed.
Even for those who remain on daily oral regimens, the trend in ARV development has been toward drugs with longer half-lives, wider safety margins, and fewer side effects. Newer single-tablet regimens condense what used to be multiple pills into one, reducing the chances of partial dosing or confusion about which pills have been taken. These improvements do not make accidental double doses impossible, but they make the consequences of one even less concerning than they were a decade or two ago.
PrEP and Double Dosing
It is worth noting that this question comes up just as often among people taking ARVs for pre-exposure prophylaxis (PrEP) as among people living with HIV. PrEP regimens typically use the same drugs, particularly tenofovir and emtricitabine, so the same principles apply. A single accidental double dose of PrEP is handled the same way: resume your normal schedule, expect that you might feel some minor stomach upset, and do not skip your next dose. The kidney considerations for TDF-based PrEP are the same as for TDF-based treatment, and the reassurance is the same too. People on event-driven (on-demand) PrEP dosing, which involves taking pills around the time of potential exposure rather than every day, sometimes worry about overlapping doses when their schedule gets compressed. The safety profile at double the standard dose is still well within tolerability for a one-off event.
If you find yourself frequently uncertain about whether you have taken your PrEP or treatment dose, that pattern is worth discussing with your prescriber. Not because occasional double doses are dangerous, but because chronic uncertainty about adherence can erode both your confidence in the medication and your actual protection against the virus. A conversation about strategies, reminders, or even switching to a long-acting option can resolve the underlying problem rather than leaving you to manage the anxiety on your own.